|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 2564 for Fgfr1

<< First    < Previous  |  Next >    Last >>
0.023s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: Not Specified
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chicken
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Gene
Type: gene
Organism: human
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3271122
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the postmitotic neurons in the cortical plate of the cerebral cortex.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the cortical plate of the cerebral cortex.
Specimen Label: Fgfr1 - E16.5
Specimen Num: 4
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271220
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Specimen Label: Fgfr1 - E12.5
Specimen Num: 2
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1754320
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: Staining is either absent or ubiquitous in the ventricular zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E12.5
Specimen Num: 2
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754322
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the ventricular zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1753720
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: There is weak, scattered staining in the mantle zone of the VMH nucleus. Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH and ARH nuclei, the AVH and anterior and posterior IDs.
Specimen Label: Fgfr1 - E12.5
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1753722
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH, VMH and ARH nuclei, the AVH and anterior and posterior IDs.
Specimen Label: Fgfr1 - E14.5
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1691319
Pattern: Non-Uniform
Stage: TS19
Assay Id: MGI:4450859
Age: embryonic day 11.5
Image: Fgfr1 - E11.5
Note: There is weak, scattered staining in the ventricular zone of the ganglionic eminences. Staining is either absent or ubiquitous in the ventricular zone of the cerebral cortex.
Specimen Label: Fgfr1 - E11.5
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271822
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: Staining is either absent or ubiquitous in the mantle zone of the premam, mam and supramam zones and the TT.
Specimen Label: Fgfr1 - E14.5
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1753920
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: There is very strong staining in the VZ of the VMH and ARH nuclei and weak, scattered staining in the anterior and posterior IDs. Staining is either absent or ubiquitous in the VZ of the dorsal and ventral POAs, the PVH nucleus and AVH.
Specimen Label: Fgfr1 - E12.5
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1691119
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:4450859
Age: embryonic day 11.5
Image: Fgfr1 - E11.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone and cortical plate of the cerebral cortex and in the mantle zone of the ganglionic eminences.
Specimen Label: Fgfr1 - E11.5
Specimen Num: 1
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754720
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: There is moderate staining in the ventricular zone of the cerebral cortex.
Specimen Label: Fgfr1 - E12.5
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754722
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the ventricular zone of the cerebral cortex.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3271020
Pattern: Scattered
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: There is weak, scattered staining in the ventricular zone of the premam, mam and supramam zones and the TT.
Specimen Label: Fgfr1 - E12.5
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:3271024
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: There is very strong staining in the ventricular zone of the premam, mam and supramam zones.
Specimen Label: Fgfr1 - E16.5
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3266520
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: There is strong staining in the ventricular zone of the ganglionic eminences and weak staining in the mantle zone of the ganglionic eminences.
Specimen Label: Fgfr1 - E12.5
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:3266524
Pattern: Non-Uniform
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: There is very strong staining in the ventricular zone of the ganglionic eminences. Staining is either absent or ubiquitous in the mantle zone of the ganglionic eminences.
Specimen Label: Fgfr1 - E16.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1690619
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:4450859
Age: embryonic day 11.5
Image: Fgfr1 - E11.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus, the prethalamus, dorsal and ventral POAs, the PVH, VMH and ARH nuclei, the AVH, the anterior and posterior IDs, the premam, mam and supramam zones and the TT.
Specimen Label: Fgfr1 - E11.5
Specimen Num: 1
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1754120
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E12.5
Specimen Num: 2
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1754122
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E14.5
Specimen Num: 3
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271120
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the cortical plate of the cerebral cortex.
Specimen Label: Fgfr1 - E12.5
Specimen Num: 2
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3271222
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271224
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Specimen Label: Fgfr1 - E16.5
Specimen Num: 4
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1754324
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: There is very strong staining in the ventricular zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E16.5
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1753724
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH, SCH, DMH, VMH and ARH nuclei, the AVH, the DAH and the PH.
Specimen Label: Fgfr1 - E16.5
Specimen Num: 4
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271820
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450859
Age: embryonic day 12.5
Image: Fgfr1 - E12.5
Note: Staining is either absent or ubiquitous in the mantle zone of the premam, mam and supramam zones and the TT.
Specimen Label: Fgfr1 - E12.5
Specimen Num: 2
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271824
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: Staining is either absent or ubiquitous in the mantle zone of the premam, mam and supramam zones.
Specimen Label: Fgfr1 - E16.5
Specimen Num: 4
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1690819
Pattern: Non-Uniform
Stage: TS19
Assay Id: MGI:4450859
Age: embryonic day 11.5
Image: Fgfr1 - E11.5
Note: Staining is strong in the AVH, moderate & scattered in anterior ID & VMH & ARH nuclei, weak & scattered in dorsal thalamus, prethalamus, dorsal & ventral POAs & posterior ID & either absent or ubiquitous in PVH nucleus & premam, mam & supramam zones & TT.
Specimen Label: Fgfr1 - E11.5
Detected: true
Specimen Num: 1
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1753922
Pattern: Non-Uniform
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is very strong staining in the ventricular zone of the ventral POA, the VMH and ARH nuclei, the AVH and anterior and posterior IDs, strong staining in the dorsal POA and moderate, scattered staining in the PVH nucleus.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1753924
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: There is very strong staining in the ventricular zone of the dorsal and ventral POAs, the PVH, SCH, DMH, VMH and ARH nuclei, the AVH, the DAH and the PH.
Specimen Label: Fgfr1 - E16.5
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1754724
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: There is very strong staining in the ventricular zone of the cerebral cortex.
Specimen Label: Fgfr1 - E16.5
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3271022
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the ventricular zone of the premam, mam and supramam zones and the TT.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3266522
Pattern: Non-Uniform
Stage: TS22
Assay Id: MGI:4450859
Age: embryonic day 14.5
Image: Fgfr1 - E14.5
Note: There is moderate, scattered staining in the ventricular zone of the ganglionic eminences. Staining is either absent or ubiquitous in the mantle zone of the ganglionic eminences.
Specimen Label: Fgfr1 - E14.5
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:3584816
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1754124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450859
Age: embryonic day 16.5
Image: Fgfr1 - E16.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus and prethalamus.
Specimen Label: Fgfr1 - E16.5
Specimen Num: 4
GXD Expression      
Probe: MGI:5556217
Assay Type: Northern blot
Annotation Date: 2014-04-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1737323
Stage: TS23
Assay Id: MGI:5556253
Age: embryonic day 15.5
Specimen Label: Fgfr1
Detected: true
Specimen Num: 1
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Publication
First Author: Kurowski A
Year: 2019
Journal: Dev Biol
Title: FGFR1 regulates trophectoderm development and facilitates blastocyst implantation.
Volume: 446
Issue: 1
Pages: 94-101
Publication
First Author: Xiao Z
Year: 2014
Journal: PLoS One
Title: Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Volume: 9
Issue: 8
Pages: e104154
Publication
First Author: Zhu X
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis.
Volume: 119
Issue: 26
Pages: e2202631119
Publication
First Author: Trokovic N
Year: 2003
Journal: Genes Dev
Title: Fgfr1 regulates patterning of the pharyngeal region.
Volume: 17
Issue: 1
Pages: 141-53
Gene
Type: gene
Organism: human
Publication
First Author: Xu X
Year: 2002
Journal: Genesis
Title: Generation of Fgfr1 conditional knockout mice.
Volume: 32
Issue: 2
Pages: 85-6
Publication      
First Author: Clark JF
Year: 2024
Journal: Genes Dev
Title: Diverse Fgfr1 signaling pathways and endocytic trafficking regulate mesoderm development.
Publication
First Author: Yang F
Year: 2013
Journal: Cancer Res
Title: FGFR1 is essential for prostate cancer progression and metastasis.
Volume: 73
Issue: 12
Pages: 3716-24
Publication  
First Author: Mierzwa AJ
Year: 2013
Journal: Neurosci Lett
Title: FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Volume: 548
Pages: 280-5
Publication
First Author: Hébert JM
Year: 2003
Journal: Development
Title: FGF signaling through FGFR1 is required for olfactory bulb morphogenesis.
Volume: 130
Issue: 6
Pages: 1101-11
Publication
First Author: Brewer JR
Year: 2015
Journal: Genes Dev
Title: Fgfr1 regulates development through the combinatorial use of signaling proteins.
Volume: 29
Issue: 17
Pages: 1863-74
Publication
First Author: Molotkov A
Year: 2017
Journal: Dev Cell
Title: Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency.
Volume: 41
Issue: 5
Pages: 511-526.e4
GXD Expression      
Probe: MGI:4354273
Assay Type: RNA in situ
Annotation Date: 2009-08-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3270422
Stage: TS22
Assay Id: MGI:4354817
Age: embryonic day 14.5
Specimen Label: Table S5 - Fgfr1
Detected: false
Specimen Num: 1
GXD Expression  
Probe: MGI:4354273
Assay Type: RNA in situ
Annotation Date: 2009-08-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3271122
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:4354817
Age: embryonic day 14.5
Note: Expression is present in the upper, but not the lower, cortical plate.
Specimen Label: Table S5 - Fgfr1
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:4354273
Assay Type: RNA in situ
Annotation Date: 2009-08-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754722
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4354817
Age: embryonic day 14.5
Specimen Label: Table S5 - Fgfr1
Detected: true
Specimen Num: 1
Publication
First Author: Fagel DM
Year: 2009
Journal: J Neurosci
Title: Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia.
Volume: 29
Issue: 4
Pages: 1202-11
Publication  
First Author: Deng Y
Year: 2023
Journal: Front Immunol
Title: Deficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS.
Volume: 14
Pages: 1041533
Publication
First Author: Hoch RV
Year: 2006
Journal: Development
Title: Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development.
Volume: 133
Issue: 4
Pages: 663-73
Publication  
First Author: Long Y
Year: 2022
Journal: Front Pharmacol
Title: Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.
Volume: 13
Pages: 1039103
Publication  
First Author: Tang Y
Year: 2023
Journal: Bone
Title: Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling.
Volume: 174
Pages: 116817
Publication
First Author: Pirvola U
Year: 2002
Journal: Neuron
Title: FGFR1 is required for the development of the auditory sensory epithelium.
Volume: 35
Issue: 4
Pages: 671-80
Publication
First Author: Ferone G
Year: 2020
Journal: Cell Rep
Title: FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
Volume: 30
Issue: 11
Pages: 3837-3850.e3
Publication
First Author: Adams AC
Year: 2012
Journal: Mol Metab
Title: The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.
Volume: 2
Issue: 1
Pages: 31-7
Publication
First Author: Calvert JA
Year: 2011
Journal: Mamm Genome
Title: A missense mutation in Fgfr1 causes ear and skull defects in hush puppy mice.
Volume: 22
Issue: 5-6
Pages: 290-305
Publication
First Author: Kovalenko D
Year: 2003
Journal: J Biol Chem
Title: Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.
Volume: 278
Issue: 16
Pages: 14087-91
Publication
First Author: Karolak MR
Year: 2015
Journal: Hum Mol Genet
Title: FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.
Volume: 24
Issue: 9
Pages: 2552-64
Publication
First Author: Kawai M
Year: 2019
Journal: Med Mol Morphol
Title: Fgfr1 conditional-knockout in neural crest cells induces heterotopic chondrogenesis and osteogenesis in mouse frontal bones.
Volume: 52
Issue: 3
Pages: 156-163
Publication
First Author: Li C
Year: 2005
Journal: Development
Title: FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis.
Volume: 132
Issue: 21
Pages: 4755-64
Publication
First Author: Wang Q
Year: 2001
Journal: Development
Title: Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
Volume: 128
Issue: 19
Pages: 3867-76
Publication
First Author: Trokovic R
Year: 2003
Journal: EMBO J
Title: FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals.
Volume: 22
Issue: 8
Pages: 1811-23
Publication
First Author: Gattineni J
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Volume: 306
Issue: 3
Pages: F351-8
Publication
First Author: Riuzzi F
Year: 2011
Journal: J Cell Sci
Title: S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner.
Volume: 124
Issue: Pt 14
Pages: 2389-400
Publication
First Author: Iseki S
Year: 1999
Journal: Development
Title: Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault.
Volume: 126
Issue: 24
Pages: 5611-20
Publication
First Author: Yang C
Year: 2012
Journal: PLoS One
Title: Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Volume: 7
Issue: 3
Pages: e33870
Publication  
First Author: Müller Smith K
Year: 2012
Journal: Brain Res
Title: Impaired motor coordination and disrupted cerebellar architecture in Fgfr1 and Fgfr2 double knockout mice.
Volume: 1460
Pages: 12-24
Publication  
First Author: Maniou E
Year: 2023
Journal: Development
Title: Caudal Fgfr1 disruption produces localised spinal mis-patterning and a terminal myelocystocele-like phenotype in mice.
Volume: 150
Issue: 19
Publication
First Author: Sims-Lucas S
Year: 2012
Journal: J Am Soc Nephrol
Title: Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme.
Volume: 23
Issue: 4
Pages: 607-17
Publication
First Author: Tole S
Year: 2006
Journal: Dev Biol
Title: Development of midline cell types and commissural axon tracts requires Fgfr1 in the cerebrum.
Volume: 289
Issue: 1
Pages: 141-51
Publication  
First Author: Deuper L
Year: 2022
Journal: Development
Title: Mesenchymal FGFR1 and FGFR2 control patterning of the ureteric mesenchyme by balancing SHH and BMP4 signaling.
Volume: 149
Issue: 17
Publication
First Author: Smith KM
Year: 2014
Journal: PLoS One
Title: Fgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbumin.
Volume: 9
Issue: 8
Pages: e103696
Publication
First Author: Han X
Year: 2016
Journal: PLoS One
Title: Conditional Deletion of Fgfr1 in the Proximal and Distal Tubule Identifies Distinct Roles in Phosphate and Calcium Transport.
Volume: 11
Issue: 2
Pages: e0147845
Publication
First Author: Ciruna BG
Year: 1997
Journal: Development
Title: Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak.
Volume: 124
Issue: 14
Pages: 2829-41
Publication
First Author: Zhou YX
Year: 2000
Journal: Hum Mol Genet
Title: A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures.
Volume: 9
Issue: 13
Pages: 2001-8
Publication
First Author: Zhang Y
Year: 2014
Journal: Int J Biol Sci
Title: Deletion of Fgfr1 in osteoblasts enhances mobilization of EPCs into peripheral blood in a mouse endotoxemia model.
Volume: 10
Issue: 9
Pages: 1064-71
Publication
First Author: Regeenes R
Year: 2018
Journal: J Biol Chem
Title: Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation.
Volume: 293
Issue: 44
Pages: 17218-17228
Publication
First Author: Partanen J
Year: 1998
Journal: Genes Dev
Title: Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos.
Volume: 12
Issue: 15
Pages: 2332-44
Publication
First Author: Kang M
Year: 2017
Journal: Dev Cell
Title: Lineage Establishment and Progression within the Inner Cell Mass of the Mouse Blastocyst Requires FGFR1 and FGFR2.
Volume: 41
Issue: 5
Pages: 496-510.e5
Publication
First Author: Wernlé KK
Year: 2023
Journal: Dev Dyn
Title: Loss of Fgfr1 and Fgfr2 in Scleraxis-lineage cells leads to enlarged bone eminences and attachment cell death.
Volume: 252
Issue: 9
Pages: 1180-1188
Publication  
First Author: Pan JA
Year: 2021
Journal: Oxid Med Cell Longev
Title: MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in Diabetes.
Volume: 2021
Pages: 9987219
Publication
First Author: Li HK
Year: 2020
Journal: Exp Cell Res
Title: LRTM1 promotes the differentiation of myoblast cells by negatively regulating the FGFR1 signaling pathway.
Volume: 396
Issue: 1
Pages: 112237
Publication
First Author: Verheyden JM
Year: 2005
Journal: Development
Title: Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning.
Volume: 132
Issue: 19
Pages: 4235-45
Publication
First Author: Hoffman MP
Year: 2002
Journal: Development
Title: Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms.
Volume: 129
Issue: 24
Pages: 5767-78